Investing in tomorrow's healthcare

Successful Investments

BeamLine Diagnostics is developing a biopsy triaging system

that can identify healthy and benign tissue specimens with

high accuracy within seconds.

HQ: Didcot
CEO: Liberty Foreman
Website: beamlinediagnostics.com

Clustermarket gives scientists the opportunity to access latest

technology in an easy and affordable way by providing an online

sharing platform.

HQ: London
CEO: Johannes Solzbach
Website: clustermarket.com

LiveSmart is developing a digital health improvement

platform that is effective at driving behaviour change.

HQ: London
CEO: Alex Heaton
Website: getlivesmart.com

The Electrospinning Company designs, develops and

manufactures biomaterials for use in regenerative medical

devices.

HQ: Oxfordshire
CEO: Ann Kramer
Website: electrospinning.co.uk

Eagle Genomics develops software solutions for

pharmaceutical, biotech and personal care product companies

to bring new candidate medicines, therapies and products to

patients and customers more quickly.

HQ: Cambridge
CEO: Abel Ureta-Vidal
Website: eaglegenomics.com

Oppilotech develops novel antibacterial compounds against drug resistant organisms.

HQ: London
CEO: Ajay Mistry
Website: oppilotech.com

mOm Incubators has developed an inexpensive, electronically controlled, inflatable infant incubator designed and

built to decrease the number of infant deaths.

HQ: London
CEO: James Roberts
Website: momincubators.com

Jupiter Diagnostics has developed a point-of-care diagnostic reader, allowing anyone to perform quick and

affordable blood tests.
HQ: London
CEO: Chris Ball
Website: jupiterdiagnostics.com

OxTex is pioneering novel tissue expander solutions for the primary use in reconstructive and dental surgery

HQ: Oxford
CEO: David Jackson
Website: oxtex.com

Camstent has invented a catheter coating to prevent infection and reduce associated costs.

HQ: Cambridge
CEO: Paul Harper
Website: camstent.com

Sense is developing user-centred, handheld diagnostic test devices in the fields of infection and oncology.

HQ: Oxford
CEO: Harry Lamble
Website: sense-bio.com

Jellagen produces research grade functional non-mammalian collagen products sourced from jellyfish.

HQ: Cardiff
CEO: Andrew Mearns Spragg
Website: jellagen.co.uk

Nalia Systems  is a developer of customisable immunodiagnostic systems that accelerate biomedical research and

drug discovery and development, producing simple, accurate and cost-effective biomarker panels that enable patient

stratification and rapid go/no-go decision making.

HQ: London
CEO: Nigel Davis
Website: naliasystems.com

StepJockey is a digital health company that creates healthy, active spaces with their unique smart signs and stair

climbing challenges.

HQ: London
CEO: Paul Nuki
Website: stepjockey.com

Desktop Genetics is building a CRISPR AI that enables scientists to modify any cell, in any species by designing and

executing personalized CRISPR genome editing, right from their desktop.

HQ: London
CEO: Riley Doyle
Website: deskgen.com

 

Become an Angels in MedCity investor

Become an investor >

 

Become an Angels in MedCity entrepreneur

Entrepreneurs >

 

On Twitter

Sign up to our #advancedtxnetwork! Become a member today and take advantage of events and networking opportunities… https://t.co/dpeUJ2EvuL
3 hours 36 min ago
#tbt Our one & only @EliasZapantis @Collab2Innovate programme manager introducing @MedCityHQ in #Cambridge last mon… https://t.co/Qt9YEwxZQD
5 days 10 hours ago